Congress Overrides Bush’s Medicare Veto
This article was originally published in The Pink Sheet Daily
Executive Summary
Doctors’ reimbursement cut is quashed; radioimmunotherapies gain special benefit.
You may also be interested in...
Medicare E-Prescribing Payments Will Piggyback Onto CMS’ Physician Quality Reporting Initiative
Implementation of new e-prescribing law expected to save $156 million in adverse drug event costs over five years.
Medicare E-Prescribing Payments Will Piggyback Onto CMS’ Physician Quality Reporting Initiative
Implementation of new e-prescribing law expected to save $156 million in adverse drug event costs over five years.
Radiopharmaceuticals May Be Eligible For ASP Reimbursement Under CMS Proposal
Two key drugs likely to be affected by such a change are Cell Therapeutics’ Zevalin and GlaxoSmithKline’s Bexxar.